title: Importance of idiopathic pulmonary fibrosis staging for clinical trial endpoints.
authors.forename: Oisin J
authors.initials: OJ
authors.lastname: O'Connell
authors.forename: Peter
authors.initials: P
authors.lastname: Riddell
authors.forename: Jim J
authors.initials: JJ
authors.lastname: Egan
mesh_terms: D017326:Clinical Trials, Phase III as Topic / Q000379:methods*; D023381:Endpoint Determination / Q000379:methods*; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000188:drug therapy*; D019141:Respiratory System Agents / Q000627:therapeutic use*
chemical_list: D019141:Respiratory System Agents